Clinical Trials Browser

Rectal Neoplasms, Colorectal Neoplasms

Carcinoma, Hepatocellular

Carcinoma, Hepatocellular

Pancreatic Ductal Adenocarcinoma

Carcinoma, Hepatocellular

Carcinoma, Hepatocellular

Carcinoma, Hepatocellular

Stomach Neoplasms

Colorectal Neoplasms, Mpox, Monkeypox

Carcinoma, Hepatocellular

Carcinoma, Hepatocellular

Pancreatic Adenocarcinoma

Biliary Tract Neoplasms

Esophageal Squamous Cell Carcinoma

Colorectal Neoplasms

Esophageal Squamous Cell Carcinoma

Carcinoma, Hepatocellular

Liver Neoplasms, Neoplasms, Hepatoblastoma

Rectal Neoplasms

Bile Duct Neoplasms, Cholangiocarcinoma

Frailty, Colonic Neoplasms, Motor Activity, Rectal Neoplasms

Stomach Neoplasms

Carcinoma, Hepatocellular

Colorectal Neoplasms

Pancreatic Neoplasms

Gastrointestinal Neoplasms, Stomach Neoplasms

Carcinoma, Hepatocellular

Carcinoma, Hepatocellular

Rectal Neoplasms

Neoplasm Metastasis, Colorectal Neoplasms

Pancreatic Neoplasms

Colorectal Neoplasms

Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Carcinoma, Hepatocellular, Liver Neoplasms

Esophageal Neoplasms

Carcinoma, Hepatocellular

Biliary Tract Neoplasms

Carcinoma, Hepatocellular

Carcinoma, Hepatocellular

Jaundice, Cholangiocarcinoma, Klatskin Tumor

Colonic Neoplasms, Colorectal Neoplasms

Neoplasms, beta-Thalassemia, Hepatoblastoma

Esophageal Neoplasms

Colonic Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Esophageal Neoplasms

Carcinoma, Hepatocellular

Clinical Trials

PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery

HCC

Hepatectomy Combined With Camrelizumab and Apatinib in CNLC Stage IIIb HCC

Combined S-1 With DC+CIK As Maintenance Therapy For Advanced Pancreatic Ductal Adenocarcinoma

TACE/HAIC Combined With Lenvatinib and Sintilimab in Neoadjuvant Therapy for Intermediate-stage HCC

ARTEMIS

JUPITER 04

Study of Tislelizumab in Combination With SOX for the Treatment of Gastric Cancer With Liver Metastases

FOS Immunohistochemical Staining of Colorectal Cancer and Its Adjacent Tissues

TACE Combined With Penpulimab and Anlotinib for Advanced HCC

Safety and Efficacy of Mitomycin C-based HIPEC After srHCC and PM of HCC

Survival Analysis After Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer and Risk Factors

The Efficacy of Chemotherapy Combined With Immunocheckpoint Inhibitors in Advanced Biliary Malignancies

Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC

Exploratory Study on Combined Conversion Immunotherapy for Liver Metastasis of MSS Type Initial Unresectable Colorectal Cancer Based on Gene Status

Comparing Paclitaxel/Cisplatin and Cisplatin/5-fluorouracil in Neo-CRT for ESCC

TACE-SBRT

sPLENTY-pc

Phase II/III Study to Assess the Efficacy of Neoadjuvant Consolidation Chemotherapy in Rectal Cancer Patients.

Percutaneous Hepatic Perfusion vs. Cisplatin/Gemcitabine in Patients With Intrahepatic Cholangiocarcinoma

Fit for Surgery. Multimodal Prehabilitation in Colorectal Cancer Patients

Safety and Efficacy of Sintilimab in Combination With Chemoradiothrapy Followed by D2 Surgical Resection in Patients With Advanced Gastric Cancer With Retroperitoneal Lymph Node Metastasis

The Efficacy and Safety of TACE, Lenvatinib and Camrelizumab in the Treatment of BCLC Stage B/C Hepatocellular Carcinoma: a Single-arm, Single-center, Open-label Study

Cetuximab Maintenance Treatment Versus Continuation After Induction Therapy in mCRC

Metronomic Chemotherapy With Capecitabine for Pancreatic Cancer

RusGCG-01

ISBRT01

A Study to Evaluate the Efficacy and Safety of Sintilimab in Combination With IBI305 (Anti-VEGF Monoclonal Antibody) Compared to Sorafenib as the First-Line Treatment for Advanced Hepatocellular Carcinoma.

SGM-LARRC

SUNRISE-CRC

The Efficacy and Safety of K-001 in the Treatment of Advanced Pancreatic Cancer

PUMP-IT

A Study of QL1604 Plus Nab-paclitaxel Versus Paclitaxel in Subjects With Advanced Gastric Cancer.

Autologous Immune Killer Cells to Treat Liver Cancer Patients as an Adjunct Therapy

Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal Carcinoma

LLTHVV

A Trial Evaluating Surufatinib Efficacy and Safety in Biliary Tract Carcinoma Patients

Lenvatinib Following Liver Transplantation in Patients With High-Risk Hepatocellular Carcinoma

Neoadjuvant Radiotherapy for HCC Involving Type I PVTT

Percutaneous Bilateral Versus Unilateral Metal Stent for Hilar Cholangiocarcinoma

FOxTROT

the Efficacy and Safety of Sugammadex in Children 0-2 Years Old

SCOPE2

The Effects of RFA in Combination With Second-line Chemotherapy and Bevacizumab on Unresectable CRLM

Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor

Study of Anlotinib in Patients With Gastric Cancer(ALTER0503)

Apatinib as Maintenance Therapy After First-line Chemotherapy(DC for 4 Cycles) in Postoperative Recurrence/Metastasis Progressive Gastric Cancer

Apatinib as Maintenance Therapy After Adjuvant Chemotherapy in Progressive Gastric Cancer With Positive Exfoliative Cancer Cells

An Exploratory Clinical Study of Apatinib for the 2nd Treatment of Esophageal Cancer or Esophageal and Gastric

HAICAT